Understanding gene regulation in kidney disease using advanced CRISPR techniques
High-throughput dissection of transcriptional regulation in kidney disease
This study is looking at how changes in the way our genes are packaged can affect kidney diseases like Adult Polycystic Kidney Disease (ADPKD), using a special tool called CRISPR to see how these changes influence gene activity, which could help create better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10914025 on NIH RePORTER |
What this research studies
This research investigates how chromatin modifications affect gene expression in kidney diseases, particularly focusing on Adult Polycystic Kidney Disease (ADPKD). By utilizing CRISPR technology, researchers aim to manipulate specific chromatin modifications and observe the resulting changes in gene expression. This approach will help identify the underlying mechanisms of gene regulation in disease states and may lead to the development of targeted therapies. The study addresses challenges related to off-target effects in CRISPR experiments to ensure accurate results.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Adult Polycystic Kidney Disease (ADPKD).
Not a fit: Patients with kidney diseases not related to ADPKD or those without significant chromatin modification issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating kidney diseases by reversing harmful gene expression changes.
How similar studies have performed: Previous research using CRISPR techniques to study gene regulation has shown promising results, indicating that this approach is both innovative and grounded in successful methodologies.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Tycko, Josh — Harvard Medical School
- Study coordinator: Tycko, Josh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.